Eric D. Mininberg
8 works · 584 citations · h-index 3
Top works
- Phase I/II Trial Evaluating the Anti-Vascular Endothelial Growth Factor Monoclonal Antibody Bevacizumab in Combination With the HER-1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib for Patients With Recurrent Non–Small-Cell Lung Cancer
- 977 Phase I/II trial evaluating blockade of tumour blood supply and tumour cell proliferation with combined bevacizumab and erlotinib HCl as targeted cancer therapy in patients with recurrent non-small cell lung cancer
- Clinical Course of 771 Patients with Bilateral Breast Cancer: Characteristics Associated with Overall and Recurrence-Free Survival
- Effect of inhibition of ornithine decarboxylase activity in a model of acute hepatocellular necrosis
- O-112 A phase I/II study of the anti-VEGF MAb bevacizumab (Avastin™) and erlotinib (Tarceva™), a HER1/EGFR-TK inhibitor: a multi-faceted approach for the treatment of recurrent non-small cell lung cancer
- Clinical course of 771 patients with bilateral breast cancer (BBC): Characteristics associated with overall and recurrence-free survival
- Use of Granulocyte Growth Factors in Breast Cancer
- Patient Demographic Form